🇺🇸 FDA
Patent

US 8580852

2-oxamide inhibitors of phospholipase A2 activity and cellular arachidonate release based on dipeptides and pseudopeptides

granted A61KA61K31/22A61P

Quick answer

US patent 8580852 (2-oxamide inhibitors of phospholipase A2 activity and cellular arachidonate release based on dipeptides and pseudopeptides) held by The Regents of the University of California expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/22, A61P, A61P29/00